Engineered tumor-targeted cytokine/antibody fusion proteins for cancer immunotherapy

被引:0
|
作者
Jamie, Spangler B. [1 ]
机构
[1] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AACR1-3
引用
收藏
页码:129 / 129
页数:1
相关论文
共 50 条
  • [1] A tumor-targeted cytokine/antibody fusion protein to stimulate anti-cancer immunity
    Silver, Aliyah Brianne
    Spangler, Jamie
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [3] Antibody–Cytokine Fusion Proteins for Cancer Immunotherapy: An Update on Recent Developments
    Dafne Müller
    BioDrugs, 2014, 28 : 123 - 131
  • [4] RECOMBINANT ANTIBODY-CYTOKINE FUSION PROTEINS FOR CANCER-IMMUNOTHERAPY
    REISFELD, RA
    BECKER, JC
    PANCOOK, JD
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 794 - 794
  • [5] Tumor-Targeted Nanomedicine for Immunotherapy
    Cabral, Horacio
    Kinoh, Hiroaki
    Kataoka, Kazunori
    ACCOUNTS OF CHEMICAL RESEARCH, 2020, 53 (12) : 2765 - 2776
  • [6] Tumor-Targeted Catalytic Immunotherapy
    Yang, En-Li
    Wang, Wu-Yin
    Liu, Ying-Qi
    Yi, Hong
    Lei, Aiwen
    Sun, Zhi-Jun
    ADVANCED MATERIALS, 2025, 37 (05)
  • [8] Engineered antibody fusion proteins for targeted disease therapy
    Silver, Aliyah B.
    Leonard, Elissa K.
    Gould, Joseph R.
    Spangler, Jamie B.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2021, 42 (12) : 1064 - 1081
  • [9] Evaluating combinations of costimulatory antibody–ligand fusion proteins for targeted cancer immunotherapy
    Nora Hornig
    Katharina Reinhardt
    Vanessa Kermer
    Roland E. Kontermann
    Dafne Müller
    Cancer Immunology, Immunotherapy, 2013, 62 : 1369 - 1380
  • [10] Combination of a Bispecific Antibody and Costimulatory Antibody-Ligand Fusion Proteins for Targeted Cancer Immunotherapy
    Hornig, Nora
    Kermer, Vanessa
    Frey, Katharina
    Diebolder, Philipp
    Kontermann, Roland E.
    Mueller, Dafne
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (05) : 418 - 429